Advances in the development of retinoids as chemopreventive agents

Journal of Nutrition

Volumn 130, Issue 2 SUPPL., 2000, Pages

  Lippman, Scott M ^a   Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemoprevention; Molecular targeting; Retinoids

Indexed keywords

CELL NUCLEUS RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RETINOID DERIVATIVE; VITAMIN D RECEPTOR;

APOPTOSIS; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; CONFERENCE PAPER; DRUG RECEPTOR BINDING; DRUG TARGETING; HUMAN; NONHUMAN; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0033981605     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/130.2.479s     Document Type: Conference Paper

References (50)

1. Bavinck, J. N., Tieben, L. M., Van der Woude, F. J., Tegzess A. M., Hermans, J., ter Schegget, J. & Vermeer, B. J. (1995) Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J. Clin. Oncol. 13:1933-1938.
2. Bischoff, E. D., Gottardis, M. M., Moon, T. E., Heyman, R. A. & Lamph, W. W. (1998) Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (Targretin) causes complete regression of mammary carcinoma. Cancer Res. 58: 479-484.
3. Bischoff, E. D., Heyman, R. A., & Lamph, W. W. (1999) Effect of the retinoid X receptor-selective ligand LGD1069 on mammary carcinoma after tamoxifen failure. J. Natl. Cancer Inst. 91: 2118-2123.
4. Chambon, P. (1996) A decade of molecular biology of retinoic acid receptors. FASEB J. 10: 940-954.
5. Chen, J.-Y., Clifford, J., Zusi, C., Starrett, J., Tortolani, D., Ostrowski, J., Reczek, P. R., Chambon, P. & Gronemeyer, H. (1996) Two distinct actions of retinoid-receptor ligands. Nature (Lond.) 382: 819-822.
6. Chiesa, F., Tradati, N., Marazza, M., Rossi, N., Boracchi, P., Mariani, L., Formelli, F., Giardini, R., Costa, A., De Palo, G. & Veronesi, U. (1993) Fenretinide (4-HPR) in chemoprevention of oral leukoplakia. J. Cell Biochem. 17F (suppl): 255-261.
7. Clifford, J. L., Menter, D. G., Wang, M., Lotan, R. & Lippman, S. M. (1999) Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells. Cancer Res. 59: 14-18.
8. Davies, P. & Lippman, S. M. (1996) Biologic basis of retinoid pharmacology: implications for cancer prevention and therapy. Adv. Oncol. 12: 2-10.
9. Edwards, L. & Jaffe, P. (1990) The effects of topical tretinoin on dysplastic nevi. Arch. Dermatol. 126: 494-499.
10. Gottardis, M. M., Bischoff, E. D., Shirley, M. A., Wagoner M. A., Lamph, W. W. & Heyman, R. A. (1996) Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand. Cancer Res. 56: 5566-5570.
11. Halpern, A. C., Schuchter, L. M., Elder, D. E., Guerry, D., IV, Elenitsas, R., Trock, B. & Matozoo, I. (1994) Effects of topical tretinoin on dysplastic nevi. J. Clin. Oncol. 12: 1028-1035.
12. Hong, W. K., Endicott, J., Itri, L. M., Doos, W., Batsakis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, C., Toth, B. B., Kramer, A., Dimery, I. W., Skipper, P. & Strong, S. (1936) 13-cis Retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med. 315: 1501-1505.
13. Hong, W. K. & Itri, L. M. (1994) Retinoids and human cancer. In: The Retinoids (Sporn, M. B., Roberts, A. B. & Goodman, D. S., eds.). pp. 597-658. Raven Press, New York, NY.
14. Hong, W. K., Lippman, S. M., Hittelman, W. N. & Lotan, R. (1995) Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic. Clin. Cancer Res. 1: 677-686.
15. Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M. Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., Dimery, I. W., Brown, B. W. & Goepfert, H. (1990) Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 323: 795-801.
16. Hong, W. K. & Sporn, M. B. (1997) Recent advances in chemoprevention of cancer. Science 278: 1073-1077.
17. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S. C., Heyman, R. A., Rose, D. W., Glass, C. K. & Rosenfeld, M. G. (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403-414.
18. Kelloff, G. J., Boone, C. W., Crowell, J. A., Steele, V. E., Lubet, R. A., Doody, L. A., Malone, W. F., Hawk, E. T. & Sigman, C. C. (1996) New agents for cancer chemoprevention. J. Cell. Biochem. 26S: 1-28.
19. Lala, D. S., Mukherjee, R., Schulman, I. G., Koch, S. S., Dardashti, L. J., Nadzan, A. M., Croston, G. E., Evans, R. M. & Heyman, R. A. (1996) Activation of specific RXR heterodimers by an antagonist of RXR homodimers. Nature (Lond.) 383: 450-453.
20. Langston, A. W., Thompson, J. R. & Gudas, L. J. (1997) Retinoic acid-responsive enhancers located 3′ of the Hox A and Hox B homeobox gene clusters. Functional analysis. J. Biol. Chem. 272: 2167-2175.
21. Lingen, M. W., Polverini, P. J. & Bouck, N. P. (1998) Retinoic acid and interferon-γ act synergistically as antiangiogenic and antitumor agents against human head and neck squamous carcinoma. Cancer Res. 58: 5551-5558.
22. Lippman, S. M., Batsakis, J. G., Toth, B. B., Weber, R. S., Lee, J. J., Martin, J. W., Hays, G. L., Goepfert, H. & Hong, W. K. (1993) Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N. Engl. J. Med. 328: 15-20.
23. Lippman, S. M., Benner, S. E. & Hong, W. K. (1994) Cancer chemoprevention. J. Clin. Oncol. 12: 851-873.
24. Lippman, S. M., Benner, S.E. & Hong, W. K. (1995) The chemoprevention of cancer. In: Cancer Prevention and Control (Greenwald, P., Kramer, R. S. & Weed, D. L., eds.), pp. 329-352. Marcel Dekker, New York, NY.
25. Lippman, S. M. & Brown, P. H. (1999) Tamoxifen prevention of breast cancer: an instance of the fingerpost. J. Natl. Cancer Inst. 91: 1809-1819.
26. Lippman, S. M., Lee, J. J. & Sabichi, A. L. (1998) Cancer chemoprevention: progress and promise. J. Natl. Cancer Inst. 90: 1514-1528.
27. Lotan, R. (1996) Retinoids in chemoprevention. FASEB J. 10: 1031-1039.
28. Lotan, R., Xu, C., Lippman, S. M., Ro, J. Y., Lee, J. S., Lee, J. J. & Hong, W. K. (1995) Suppression of retinoic acid receptor beta in oral premalignant lesions and its upregulation by isotretinoin. N. Engl. J. Med. 332: 1405-1410.
29. Meyskens, F. L., Surwit, E, Moon, T. E., Childers, J. M., David J. R., Dorr, R. T., Johnson, C. S. & Alberts, D. S. (1994) Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J. Natl. Cancer Inst. 86: 539-543.
30. Moon, R. C., Mehta, R. G. & Rao, K.J.V.N. (1994) Retinoids and cancer in experimental animals. In: The Retinoids (Sporn, M. B., Roberts, A. B. & Goodman, D. S., eds.), pp. 573-595. Raven Press, New York, NY.
31. Moon, T. E., Levine, N., Cartmel, B. & Bangert, J. L. (1997a) Retinoids in prevention of skin cancer. Cancer Lett. 114: 203-205.
32. Moon, T. E., Levine N., Cartmel, B., Bangert, J. L., Rodney, S., Dong, Q., Peng, Y. M. & Alberts, D. S. (1997b) Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol. Biomark. Prev. 6: 949-956.
33. Mukherjee, R., Davies, P. J., Crombie, D. L., Bischoff, E. D., Cesario, R. M., Jow, L., Hamann, L. G., Boehm, M. F., Mondon, C. E., Nadzan, A. M., Paterniti, J. R. & Heyman, R. A. (1997) Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature (Lond.) 386: 407-410.
34. Mukherjee, R., Strasser, J., Jow, L., Hoener, P., Paterniti, J. R., Jr. & Heyman, R. A. (1998) RXR agonists activate PPARalpha-inducible genes, lower triglycerides, and raise HDL levels in vitro. Arterioscler. Thromb. Vasc. Biol. 18: 272-276.
35. Mulshine, J. L., De Luca, L. M. & Dedrick, R. L. (1998) Regional delivery of retinoids: a new approach to early lung cancer intervention. Clin. Biol. Basis Lung Cancer Prev. 24: 273-283.
36. Muto, Y., Moriwaki, H., Ninomiya, M., Adachi, S., Saito, A. & Takasaki, K. T. (1996) Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N. Engl. J. Med. 334: 1561-1567.
37. Nagy, L., Thomazy, V. A., Heyman, R. A. & Davies, P. J. A. (1998) Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Diffn. 5: 11-19.
38. Oridate, N., Suzuki, S., Higuchi, M., Mitchell M. F., Hong W. K. & Lotan, R. (1997) Involvement of reactive oxygen species in N-(4-hydroxyphenyl) retinamide-induced apoptosis in cervical carcinoma cells. J. Natl. Cancer Inst. 89: 1191-1198.
39. Pastorino, U., Infante, M., Maioli, M., Chiesa, G., Buyse, M., Firket, P., Rosmentz, N., Cherici, M., Soresi, E., Valente, M., Belloni, P. A. & Ravasi, G. (1993) Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J. Clin. Oncol. 11: 1216-1222.
40. Peck, G. L. & DiGiovanna, J. J. (1994) Synthetic retinoids in dermatology. In: The Retinoids (Sporn, M. B., Roberts, A. B., Goodman, D. S., eds.), pp. 631-658. Raven Press, New York, NY.
41. Perlmann, T. & Evans, R. M. (1997) Nuclear receptors in Sicily: all in the familia. Cell 90: 391-397.
42. Pfahl, M. (1993) Nuclear receptor/AP-1 interaction. Endocr. Rev. 14: 651-657.
43. Rook, A. H., Jaworsky, C., Nguyen, T., Grossman, R. A., Wolfe, J. T., Witmer, W. K. & Kligman, A. M. (1995) Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. Transplantation 59: 714-719.
44. Studer, U. E., Jenzer, S., Biedermann, C., Chollet, D., Kraft, R., von Toggenburg, H. & Vonbank, F. (1995) Adjuvant treatment with vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors-final analysis of a prospective randomized multicenter trial in Switzerland. Eur. Ural. 28: 284-90.
45. Torchia J., Glass C. & Rosenfeld M. G. (1998) Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell Biol. 10: 373-383.
46. Veronesi, U., De Palo, G., Marubini, E., Costa, A., Formelli, F., Mariani, L., Decensi, A., Camerini, T., Del Turco, M. R., Di Mauro, M. G., Muraca, M. G., Del Vecchio, M., Pinto, C., D'Aiuto, G., Boni, C., Campa, T., Magni, A., Miceli, R., Perloff, M., Malone, W. F. & Sporn, M. B. (1999) A randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J. Natl. Cancer Inst. 91: 1847-1856.
47. Weihua, X., Kolla, V. & Kalvakolanu, D. V. (1997) Modulation of interferon action by retinoids. J. Biol. Chem. 272: 9742-9748.
48. Xu, X. C., Lee, J. S., Lee, J. J., Morice, R. C., Liu, X., Lippman, S. M., Hong, W. K. & Lotan, R. (1999) Nuclear retinoid receptor beta in bronchial epithelium of smokers before and during chemoprevention. J. Natl. Cancer Inst. 91: 1317-1321.
49. Xu, X.-C., Sozzi, G, Lee, J. S., Lee, J. J., Pastorino, U., Pilotti, S., Kurie, J. M., Hong, W. K. & Lotan, R. (1997) Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. J. Natl. Cancer Inst. 89: 624-629.
50. Zhou, X. F., Shen, X. Q. & Shemshedini L. (1999) Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization. Mol. Endocrinol. 13: 276-285.